ExodusPoint Capital Management, LP
Position in VKTX — Viking Therapeutics, Inc.
CIK 1736225
NEW YORK, NY
Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,087,525
+$11,821,863 QoQ
Shares Held
361,126
+418.7% QoQ
Ownership
0.310%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#41
of 434 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Jun 30, 2026CallValue
$15,330,930
CallShares
393,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $275,175,559 across 100 Biotechnology names. VKTX ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
This page
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in VKTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,087,525 | 361,126 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $15,330,930 | 393,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $4,461,234 | 137,100 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $2,265,662 | 69,627 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,482,752 | 326,400 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $25,406,960 | 722,199 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,366,113 | 204,190 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $525,600 | 20,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $530,000 | 20,000 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $1,025,974 | 38,716 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,447,911 | 349,810 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $483,000 | 20,000 | Call | Sole | 2025-05-14 | |
| 2024-12-31 | $12,647,432 | 314,300 | Call | Sole | 2025-02-12 | |
| 2024-12-31 | $9,476,640 | 235,503 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $16,660,596 | 263,159 | Shares | Sole | 2024-11-12 | |
| 2024-09-30 | $9,566,141 | 151,100 | Call | Sole | 2024-11-12 | |
| 2024-06-30 | $2,805,819 | 52,930 | Shares | Sole | 2024-08-13 | |
| 2024-06-30 | $14,551,245 | 274,500 | Call | Sole | 2024-08-13 | |
| 2024-03-31 | $2,410,800 | 29,400 | Call | Sole | 2024-05-14 | |
| 2024-03-31 | $1,155,790 | 14,095 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,262,297 | 67,829 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $83,648 | 30,753 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $70,056 | 24,241 | Shares | Sole | 2022-08-22 | |
| 2021-09-30 | $153,263 | 24,405 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $453,083 | 75,640 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $374,964 | 59,283 | Shares | Other | 2021-05-17 | |
| 2020-06-30 | $190,841 | 26,469 | Shares | Other | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||